St. Jude Medical
Medical-device maker St. Jude Medical’s first-quarter net income rose almost 12 percent, helped by higher sales of its implantable defibrillators and devices that treat a type of irregular heartbeat. The company said four new product approvals in the U.S. will boost sales in the second half of the year and gave guidance within range of analyst expectations.
St. Jude Medical says it will announce Monday that it received European approval to market the first pacemaker that does not require wires to attach to the heart. The first-of-a-kind device was developed by California-based startup, Nanostim, with funding from St. Jude.
It’s a source of pride for many Minnesotans – the number of Fortune 500 companies that call Minnesota home. “We live in an amazing state, so I thought a big percentage were here,” said Diane Anderson, of Minneapolis.
In another blow to Minnesota’s work force, St. Jude Medical has announced layoffs as part of a restructuring plan to deal with slumping sales.
Thomson Reuters, a company that employs many Minnesotans, said Friday that it opposes the proposed constitutional amendment that would limit the freedom for same-sex couples to marry in the state of Minnesota.
People supporting the amendment to ban same sex marriage in Minnesota will be protesting the rest of the week at General Mills headquarters in Golden Valley.
Medical device maker St. Jude Medical Inc. said Tuesday its board authorized a share repurchase of up to $300 million and declared a fourth-quarter dividend of 21 cents.
St. Jude Medical Inc. says a Los Angeles jury awarded it $2.3 billion in a lawsuit against a former employee of its heart device business and a Chinese company he founded.
St. Jude Medical Inc. said Thursday it will pay $16 million as part of a settlement with the U.S. Department of Justice over allegations the medical device maker paid kickbacks to physicians to implant its pacemakers and defibrillators.